InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Neurogene Inc.

NGNE Clue Score33
United States Fiscal year ends December CIK 0001404644
$26.40 -0.38% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $26.40 +300.61% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−37.6Net income−37.0Fiscal year 2017Operating income−51.1Net income−50.2Fiscal year 2018Revenue25.0Operating income−32.6Net income−31.6Fiscal year 2019Operating income−71.0Net income−69.4Fiscal year 2020Operating income−33.7Net income−33.3EPS, diluted−0.64Fiscal year 2021Operating income−60.7Net income−60.7EPS, diluted−1.10Fiscal year 2022Operating income−56.5Net income−55.2EPS, diluted−1.04Fiscal year 2023Revenue0.0Operating income−55.6Net income−36.3Fiscal year 2024Revenue0.9Operating income−82.6Net income−75.1EPS, diluted−4.28Fiscal year 2025Revenue0.0 −100.0%Operating income−103.3Net income−90.4EPS, diluted−4.24
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 25.0 n/a n/a n/a n/a 0.0 0.9 0.0
Growth −100.0%
Operating income −37.6 −51.1 −32.6 −71.0 −33.7 −60.7 −56.5 −55.6 −82.6 −103.3
Net income −37.0 −50.2 −31.6 −69.4 −33.3 −60.7 −55.2 −36.3 −75.1 −90.4
Growth
EPS, diluted n/a n/a n/a n/a −0.64 −1.10 −1.04 n/a −4.28 −4.24

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Operating margin−130.5%Net margin−126.3%Free cash flow margin−126.5%Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Operating margin−8,930.3%Net margin−8,123.7%Free cash flow margin−7,720.1%Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a −130.5% n/a n/a n/a n/a n/a −8,930.3% n/a
Net margin n/a n/a −126.3% n/a n/a n/a n/a n/a −8,123.7% n/a
Free cash flow margin n/a n/a −126.5% n/a n/a n/a n/a n/a −7,720.1% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−30.2Capital expenditure−0.7Free cash flow−30.9Fiscal year 2017Operating cash flow−44.7Capital expenditure−0.5Free cash flow−45.2Fiscal year 2018Operating cash flow−31.6Capital expenditure−0.0Free cash flow−31.6Fiscal year 2019Operating cash flow−15.4Capital expenditure−0.9Free cash flow−16.3Fiscal year 2020Operating cash flow−24.6Capital expenditure−2.2Free cash flow−26.8Fiscal year 2021Operating cash flow−47.6Capital expenditure−3.3Free cash flow−50.8Fiscal year 2022Operating cash flow−52.8Capital expenditure−2.2Free cash flow−55.1Fiscal year 2023Operating cash flow−51.4Capital expenditure−0.3Free cash flow−51.7Fiscal year 2024Operating cash flow−70.6Capital expenditure−0.8Free cash flow−71.4Fiscal year 2025Operating cash flow−77.2Capital expenditure−1.2Free cash flow−78.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −30.2 −44.7 −31.6 −15.4 −24.6 −47.6 −52.8 −51.4 −70.6 −77.2
Capital expenditure −0.7 −0.5 −0.0 −0.9 −2.2 −3.3 −2.2 −0.3 −0.8 −1.2
Free cash flow −30.9 −45.2 −31.6 −16.3 −26.8 −50.8 −55.1 −51.7 −71.4 −78.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash32.3Shareholders’ equity144.7Fiscal year 2017Cash52.0Shareholders’ equity98.9Fiscal year 2018Cash76.9Shareholders’ equity72.7Fiscal year 2019Cash143.1Shareholders’ equity141.7Fiscal year 2020Cash192.6Shareholders’ equity191.2Fiscal year 2021Cash142.5Shareholders’ equity−91.9Fiscal year 2022Cash82.0Shareholders’ equity−145.7Fiscal year 2023Cash148.2Shareholders’ equity186.0Fiscal year 2024Cash136.6Shareholders’ equity310.4Fiscal year 2025Cash103.8Shareholders’ equity264.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 32.3 52.0 76.9 143.1 192.6 142.5 82.0 148.2 136.6 103.8
Shareholders’ equity 144.7 98.9 72.7 141.7 191.2 −91.9 −145.7 186.0 310.4 264.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Operations
−30.2 −44.7 −31.6 −15.4 −24.6 −47.6 −52.8 −51.4 −70.6 −77.2
Growth
n/a 0.4 0.3 0.3 0.8 1.3 3.2 3.3 3.2 3.0
Investment
−0.7 −0.5 −0.0 −0.9 −2.2 −3.3 −2.2 −0.3 −0.8 −1.2
calc −30.9 −45.2 −31.6 −16.3 −26.8 −50.8 −55.1 −51.7 −71.4 −78.4
Growth
calc n/a n/a n/a n/a −0.52 −0.92 −1.00 n/a −4.07 −3.67
−48.1 64.0 56.0 −0.7 −2.2 −3.3 −2.2 25.6 −125.3 14.0
Financing
71.1 0.4 0.6 82.2 77.1 0.7 66.5 92.5 184.1 30.4

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.